Lymphocyte abnormalities in patients with macro- and micro-prolactinoma: different effects of bromocriptine treatment in the two groups.
De Bernardi
B
B
Institute of Internal Medicine, Infectious Diseases and Immunopathology, University of Milan, Italy.
Scorza
R
R
Hu
C
C
Travaglini
P
P
Della Casa Alberighi
O
O
Togni
M E
ME
Honorati
C
C
Cigognini
A
A
D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000032:analysis*; D001971:Bromocriptine / Q000627:therapeutic use*; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D010911:Pituitary Neoplasms / Q000097:blood / Q000145:classification / Q000188:drug therapy / Q000276:immunology*; D011388:Prolactin / Q000097:blood; D015175:Prolactinoma / Q000097:blood / Q000145:classification / Q000188:drug therapy / Q000276:immunology*; D012016:Reference Values
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D006684:HLA-DR Antigens; D001971:Bromocriptine; D011388:Prolactin